Pyruvate dehydrogenase operates as an intramolecular nitroxyl generator during macrophage metabolic reprogramming
Name:
s41467-023-40738-4.pdf
Size:
3.605Mb
Format:
PDF
Description:
Final Published Version
Author
Palmieri, E.M.Holewinski, R.
McGinity, C.L.
Pierri, C.L.
Maio, N.
Weiss, J.M.
Tragni, V.
Miranda, K.M.
Rouault, T.A.
Andresson, T.
Wink, D.A.
McVicar, D.W.
Affiliation
Department of Chemistry and Biochemistry, University of ArizonaIssue Date
2023-08-22
Metadata
Show full item recordPublisher
Nature ResearchCitation
Palmieri, E.M., Holewinski, R., McGinity, C.L. et al. Pyruvate dehydrogenase operates as an intramolecular nitroxyl generator during macrophage metabolic reprogramming. Nat Commun 14, 5114 (2023). https://doi.org/10.1038/s41467-023-40738-4Journal
Nature CommunicationsRights
This is a U.S.Government work and not under copyright protection in the US; foreign copyright protection may apply 2023. This article is licensed under a Creative Commons Attribution 4.0 International License.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
M1 macrophages enter a glycolytic state when endogenous nitric oxide (NO) reprograms mitochondrial metabolism by limiting aconitase 2 and pyruvate dehydrogenase (PDH) activity. Here, we provide evidence that NO targets the PDH complex by using lipoate to generate nitroxyl (HNO). PDH E2-associated lipoate is modified in NO-rich macrophages while the PDH E3 enzyme, also known as dihydrolipoamide dehydrogenase (DLD), is irreversibly inhibited. Mechanistically, we show that lipoate facilitates NO-mediated production of HNO, which interacts with thiols forming irreversible modifications including sulfinamide. In addition, we reveal a macrophage signature of proteins with reduction-resistant modifications, including in DLD, and identify potential HNO targets. Consistently, DLD enzyme is modified in an HNO-dependent manner at Cys477 and Cys484, and molecular modeling and mutagenesis show these modifications impair the formation of DLD homodimers. In conclusion, our work demonstrates that HNO is produced physiologically. Moreover, the production of HNO is dependent on the lipoate-rich PDH complex facilitating irreversible modifications that are critical to NO-dependent metabolic rewiring. © 2023, Springer Nature Limited.Note
Open access journalISSN
2041-1723PubMed ID
37607904Version
Final Published Versionae974a485f413a2113503eed53cd6c53
10.1038/s41467-023-40738-4
Scopus Count
Collections
Except where otherwise noted, this item's license is described as This is a U.S.Government work and not under copyright protection in the US; foreign copyright protection may apply 2023. This article is licensed under a Creative Commons Attribution 4.0 International License.
Related articles
- Persistent susceptibility of cathepsin B to irreversible inhibition by nitroxyl (HNO) in the presence of endogenous nitric oxide.
- Authors: Väänänen AJ, Salmenperä P, Hukkanen M, Miranda KM, Harjula A, Rauhala P, Kankuri E
- Issue date: 2008 Sep 15
- Cathepsin B is a differentiation-resistant target for nitroxyl (HNO) in THP-1 monocyte/macrophages.
- Authors: Väänänen AJ, Salmenperä P, Hukkanen M, Rauhala P, Kankuri E
- Issue date: 2006 Jul 1
- Nitric oxide orchestrates metabolic rewiring in M1 macrophages by targeting aconitase 2 and pyruvate dehydrogenase.
- Authors: Palmieri EM, Gonzalez-Cotto M, Baseler WA, Davies LC, Ghesquière B, Maio N, Rice CM, Rouault TA, Cassel T, Higashi RM, Lane AN, Fan TW, Wink DA, McVicar DW
- Issue date: 2020 Feb 4
- Glutathione sulfinamide serves as a selective, endogenous biomarker for nitroxyl after exposure to therapeutic levels of donors.
- Authors: Johnson GM, Chozinski TJ, Gallagher ES, Aspinwall CA, Miranda KM
- Issue date: 2014 Nov
- Identification of nitroxyl-induced modifications in human platelet proteins using a novel mass spectrometric detection method.
- Authors: Hoffman MD, Walsh GM, Rogalski JC, Kast J
- Issue date: 2009 May